{"id":7575,"date":"2026-03-01T21:59:08","date_gmt":"2026-03-01T21:59:08","guid":{"rendered":"https:\/\/live-cancer-factfinder.pantheonsite.io\/fact-finder-tool\/machin-rife-yo-ka-geri-kanse-cheche-enfomasyon-sou-kanse\/"},"modified":"2026-10-20T16:51:05","modified_gmt":"2026-10-20T16:51:05","slug":"machin-rife-yo-ka-geri-kanse-cheche-enfomasyon-sou-kanse","status":"publish","type":"post","link":"https:\/\/cancerfactfinder.org\/ht\/zouti-pou-cheche-enfomasyon\/machin-rife-yo-ka-geri-kanse-cheche-enfomasyon-sou-kanse\/","title":{"rendered":"AFIKASYON: Machin Rife yo ka geri kans\u00e8"},"content":{"rendered":"\n<h2 class=\"wp-block-heading\">Sa ou ka tande<\/h2>\n\n<p class=\"wp-block-paragraph\">Machin Rife a ka geri kans\u00e8 l\u00e8 l s\u00e8vi av\u00e8k frekans elektwomayetik ki vize epi detwi selil kans\u00e8 yo.<\/p>\n\n<h2 class=\"wp-block-heading\">Sa syans di nou<\/h2>\n\n<p class=\"wp-block-paragraph\">Machin Rife a, ke Royal Raymond Rife te devlope nan ane 1920 yo, se yon apar\u00e8y ki jenere vag elektwomayetik ki gen ti en\u00e8ji, menm jan ak vag radyo. Moun ki sip\u00f2te machin nan deklare ke vag sa yo ka vize epi detwi selil kans\u00e8 yo l\u00e8 yo matche ak frekans espesifik yo a. <\/p>\n\n<h3 class=\"wp-block-heading\">Pr\u00e8v Epidemyolojik<\/h3>\n\n<p class=\"wp-block-paragraph\">Pa gen okenn etid epidemyolojik sou gwo ech\u00e8l ki konfime efikasite machin Rife yo nan tretman kans\u00e8. Pif\u00f2 pr\u00e8v yo rete anekdotik epi yo pa gen validasyon syantifik. FDA a pa apwouve machin Rife a pou okenn itilizasyon, epi \u00f2ganizasyon ki gen bon repitasyon tankou Sosyete Ameriken pou Kans\u00e8 a te demanti deklarasyon li yo.  <\/p>\n\n<h3 class=\"wp-block-heading\">Pr\u00e8v Laboratwa\/Pr\u00e8v Sip\u00f2<\/h3>\n\n<p class=\"wp-block-paragraph\">Etid laboratwa yo pa demontre ke machin Rife a ka efektivman vize epi detwi selil kans\u00e8 yo. Gen k\u00e8k etid sou ond elektwomayetik menm jan an ki sijere ke yo ta ka anpeche k\u00e8k selil kans\u00e8 grandi san afekte selil n\u00f2mal yo, men etid sa yo te f\u00e8t nan laboratwa, pa sou moun, epi yo te itilize frekans diferan de machin Rife a.   <\/p>\n\n<h3 class=\"wp-block-heading\">Klasifikasyon kanseroj\u00e8n IARC:  <\/h3>\n\n<p class=\"wp-block-paragraph\">pa klase<\/p>\n\n<h2 class=\"wp-block-heading\">Kijan pou diminye risk ou<\/h2>\n\n<ul class=\"wp-block-list\">\n<li>Swiv tretman kans\u00e8 ki baze sou pr\u00e8v, tankou operasyon, chimyoterapi, radyasyon, ak terapi sib preskri pa pwofesyon\u00e8l medikal yo.<\/li>\n\n\n\n<li>F\u00e8 t\u00e8s depistaj regilye ak mezi prevantif, tankou kenbe yon rejim alimant\u00e8 ki an sante, f\u00e8 egz\u00e8sis, evite tabak, epi limite konsomasyon alk\u00f2l.<\/li>\n\n\n\n<li>Konsilte av\u00e8k pwofesyon\u00e8l swen sante yo anvan ou konsidere l\u00f2t tretman, pou asire w ke yo itilize yo ansanm ak swen medikal estanda a, pa k\u00f2m yon ranplasman pou li.<\/li>\n<\/ul>\n\n<h2 class=\"wp-block-heading\">Liy final la<\/h2>\n\n<p class=\"wp-block-paragraph\">Afimasyon ki di machin Rife yo ka geri kans\u00e8 a se fo. Pa gen okenn pr\u00e8v syantifik ki sip\u00f2te deklarasyon sa a, epi konte sou tretman sa yo ka retade efikasite swen medikal la. <\/p>\n","protected":false},"excerpt":{"rendered":"<p>Sa ou ka tande Machin Rife a ka geri kans\u00e8 l\u00e8 l s\u00e8vi av\u00e8k frekans elektwomayetik ki vize epi detwi selil kans\u00e8 yo. Sa syans di nou Machin Rife a, ke Royal Raymond Rife te devlope nan ane 1920 yo, se yon apar\u00e8y ki jenere vag elektwomayetik ki gen ti en\u00e8ji, menm jan ak vag&hellip;<\/p>\n","protected":false},"author":9,"featured_media":7539,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[522,553],"tags":[514],"class_list":["post-7575","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pwoblem-medikal-oswa-tretman","category-pwodwi-konsomate-yo","tag-definitivman-oubyen-pwobableman-pa-vre"],"acf":[],"_links":{"self":[{"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/posts\/7575","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/comments?post=7575"}],"version-history":[{"count":5,"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/posts\/7575\/revisions"}],"predecessor-version":[{"id":18136,"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/posts\/7575\/revisions\/18136"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/media\/7539"}],"wp:attachment":[{"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/media?parent=7575"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/categories?post=7575"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cancerfactfinder.org\/ht\/wp-json\/wp\/v2\/tags?post=7575"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}